ArticleGastroenterology2022

IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma.

Vikas K Somani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.